DRKS00032146招募中不适用
OPTILATER - Optimal long-term survival after cancer - OPTILATER
niversitätsklinikum Essen (Westdeutsches Tumorzentrum)0 个研究点目标入组 3,000 人开始时间: 2024年3月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 5 Years 至 one（—）
- 性别
- All
入选标准
- •Patients who have been diagnosed with cancer at least five years ago are included in the trial.
排除标准
- •Patients who have been diagnosed with cancer under five years ago will not be included in the trial.
研究者
相似试验
招募中
不适用
Investigation of survival factors for cancer patients using data science methodsJPRN-UMIN000047446Japanese Society on Inflammation and Metabolism in Cancer300
进行中（未招募）
1 期
ong-term treatment of cancer associated VTE: reduced vs full dose of apixaban : API-CAT STUDY for APIxaban Cancer Associated ThrombosisPatients with breast, prostate, and colorectal active cancer, with objectively documented index event of symptomatic or incidental proximal DVT or symptomatic or incidental PE, after 6 months of anticoagulant therapy for the treatment of the index event, with no objectively documented symptomatic recurrence of VTE between the index event and randomization.MedDRA version: 20.0Level: LLTClassification code 10076654Term: Cancer-associated thrombosisSystem Organ Class: 100000004864EUCTR2017-003342-25-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,722
进行中（未招募）
1 期
ong-term treatment of cancer associated VTE: reduced vs full dose of apixaban : API-CAT STUDY for APIxaban Cancer Associated ThrombosisAny cancer diagnosed histologically (other than basal-cell or squamous-cell carcinoma of the skin, primary brain tumor or intra-cerebral metastasis, with objectively documented index event of symptomatic or incidental proximal DVT or symptomatic or incidental PE, afterat least 6 months of anticoagulant therapy for the treatment of the index event, with no objectively documented symptomatic recurrence of VTE between the index event and randomization.MedDRA version: 21.1Level: LLTClassification code 10076654Term: Cancer-associated thrombosisSystem Organ Class: 100000004864EUCTR2017-003342-25-GRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,722
已完成
不适用
Prognostic index for overall survival in malignant mesothelioma: external validation.malignant pleural mesotheliomaJPRN-UMIN000018143Hyogo Prefectural Amagasaki General Medical Center160
招募中
Unknown
ongterm survival rate and possible complications of narrow diameter Implants PF 3.0 in the aesthetic areanarrow diameter implants in the esthetic zoneDRKS00032708Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirugie-plastische Operationen30